Nordea Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.72M | Buy |
58,660
+28
| +0% | +$3.21K | 0.01% | 501 |
|
2025
Q1 | $6.17M | Buy |
58,632
+60
| +0.1% | +$6.31K | 0.01% | 496 |
|
2024
Q4 | $6.25M | Buy |
58,572
+2,970
| +5% | +$317K | 0.01% | 500 |
|
2024
Q3 | $5.48M | Sell |
55,602
-3,097
| -5% | -$305K | 0.01% | 516 |
|
2024
Q2 | $4.87M | Sell |
58,699
-9,629
| -14% | -$799K | 0.01% | 533 |
|
2024
Q1 | $4.94M | Sell |
68,328
-643
| -0.9% | -$46.4K | 0.01% | 539 |
|
2023
Q4 | $4.93M | Sell |
68,971
-2,381
| -3% | -$170K | 0.01% | 524 |
|
2023
Q3 | $4.39M | Sell |
71,352
-796
| -1% | -$49K | 0.01% | 530 |
|
2023
Q2 | $5.27M | Buy |
72,148
+505
| +0.7% | +$36.9K | 0.01% | 507 |
|
2023
Q1 | $5.18M | Sell |
71,643
-2,230
| -3% | -$161K | 0.01% | 513 |
|
2022
Q4 | $4.88M | Sell |
73,873
-38,241
| -34% | -$2.52M | 0.01% | 527 |
|
2022
Q3 | $6.1M | Sell |
112,114
-377
| -0.3% | -$20.5K | 0.01% | 468 |
|
2022
Q2 | $6.09M | Sell |
112,491
-3,475
| -3% | -$188K | 0.01% | 482 |
|
2022
Q1 | $8.46M | Buy |
115,966
+1,454
| +1% | +$106K | 0.01% | 456 |
|
2021
Q4 | $11.2M | Sell |
114,512
-851
| -0.7% | -$83K | 0.01% | 386 |
|
2021
Q3 | $10.1M | Sell |
115,363
-1,759
| -2% | -$154K | 0.01% | 401 |
|
2021
Q2 | $9.59M | Buy |
117,122
+13,074
| +13% | +$1.07M | 0.01% | 408 |
|
2021
Q1 | $9.96M | Sell |
104,048
-2,037
| -2% | -$195K | 0.01% | 379 |
|
2020
Q4 | $6.58M | Buy |
106,085
+39,503
| +59% | +$2.45M | 0.01% | 448 |
|
2020
Q3 | $4.07M | Sell |
66,582
-65,714
| -50% | -$4.02M | 0.01% | 547 |
|
2020
Q2 | $9.42M | Buy |
132,296
+66,443
| +101% | +$4.73M | 0.01% | 468 |
|
2020
Q1 | $3.03M | Buy |
65,853
+2,664
| +4% | +$123K | 0.01% | 567 |
|
2019
Q4 | $4.14M | Buy |
63,189
+1,663
| +3% | +$109K | 0.01% | 605 |
|
2019
Q3 | $3.84M | Buy |
61,526
+20,270
| +49% | +$1.26M | 0.01% | 611 |
|
2019
Q2 | $2.94M | Buy |
41,256
+12,808
| +45% | +$912K | 0.01% | 674 |
|
2019
Q1 | $2.23M | Sell |
28,448
-1,267
| -4% | -$99.4K | ﹤0.01% | 848 |
|
2018
Q4 | $2.52M | Sell |
29,715
-102
| -0.3% | -$8.64K | 0.01% | 787 |
|
2018
Q3 | $5.11M | Buy |
29,817
+4,228
| +17% | +$724K | 0.01% | 546 |
|
2018
Q2 | $3.31M | Sell |
25,589
-6,423
| -20% | -$830K | 0.01% | 584 |
|
2018
Q1 | $3.3M | Buy |
32,012
+2,756
| +9% | +$284K | 0.01% | 538 |
|
2017
Q4 | $2.5M | Buy |
29,256
+1,606
| +6% | +$137K | 0.01% | 591 |
|
2017
Q3 | $2.35M | Buy |
27,650
+784
| +3% | +$66.6K | 0.01% | 586 |
|
2017
Q2 | $2.04M | Buy |
26,866
+3,361
| +14% | +$255K | 0.01% | 576 |
|
2017
Q1 | $1.55M | Buy |
23,505
+5,346
| +29% | +$353K | ﹤0.01% | 662 |
|
2016
Q4 | $1.15M | Buy |
18,159
+1,244
| +7% | +$78.9K | ﹤0.01% | 712 |
|
2016
Q3 | $1.08M | Buy |
16,915
+8,672
| +105% | +$552K | ﹤0.01% | 708 |
|
2016
Q2 | $613K | Buy |
+8,243
| New | +$613K | ﹤0.01% | 691 |
|